Patent assignee · FR · COMPANY

L'Universite Montpellier II

15Patents
7Active
15Granted
42Portfolio score

Filing activity: Jun 15, 2001 → Mar 22, 2013 · 5 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7608600B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 144 Expired
US7635689B2 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Chemistry; Metallurgy 93 Expired
US7951789B2 Compounds and pharmaceutical compositions for the treatment of viral infections Chemistry; Metallurgy 69 Active
US7625875B2 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Human Necessities 67 Expired
US7902202B2 Compounds and pharmaceutical compositions for the treatment of viral infections Chemistry; Metallurgy 60 Active
US7582618B2 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections Human Necessities 58 Active
US7662798B2 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Human Necessities 55 Expired
US8637475B1 Modified 2′ and 3′ nucleoside prodrugs for treating flaviviridae infections Chemistry; Metallurgy 50 Active
US6875751B2 3′-prodrugs of 2′-deoxy-β-L-nucleosides Chemistry; Metallurgy 45 Expired
US7585851B2 3′-prodrugs of 2′-deoxy-β-L-nucleosides Chemistry; Metallurgy 26 Expired
US8742101B2 Purine nucleoside analogues for treating flaviviridae including hepatitis C Chemistry; Metallurgy 23 Active
US6946450B2 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Chemistry; Metallurgy 23 Expired
US7304043B2 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Chemistry; Metallurgy 2 Expired
US7795238B2 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Chemistry; Metallurgy 1 Active
US9290533B2 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.